The Drosophila sex determination gene Sex-lethal controls its own expression and the expression of downstream target genes such as transformer by regulating RNA splicing. Genetic and molecular studies have established that Sxl requires the product of another gene, snf, to autoregulate the splicing of its own transcripts. snf has recently been shown to encode a Drosophila U1 and U2 small nuclear ribonucleoprotein particle protein.
In the fruit fly Drosophila melanogaster, the activity state of the binary switch gene, Sex-lethal (Sxl), is set early in development in response to the primary sex determination signal, the X chromosome-to-autosome ratio (15, 17, 20, 32) . Sxl is turned on in 2X/2A animals (females) by activating a posttranscriptional autoregulatory feedback loop (4, 14) . In this feedback loop, Sxl proteins promote their own synthesis by directing the female-specific splicing of Sxl transcripts originating from the Sxl maintenance promoter, Sxl-Pm (4) . This autoregulatory feedback loop is responsible for maintaining the female-determined state during most of development. The Sxl autoregulatory feedback loop is not activated in 1X/2A animals (males), and Sxl-Pm transcripts are spliced in the nonproductive default mode. The critical difference between the Sxl mRNAs in the two sexes is the male-specific exon, L3 (Fig. 1 ). This exon contains in-frame translation stop signals that prematurely truncate an open reading frame which begins in exon L2 (5) . Exon L3 is included in all male Sxl mRNAs, and these RNAs encode only very short, presumably nonfunctional polypeptides. In females, the Sxl protein mediates the skipping of the male exon, joining exon L2 to L4. This joining creates a long open frame which is predicted to encode protein species with sizes of about 35 kDa that contain two RNA recognition motif (RRM) domains (48, 50) .
Sxl controls sexual differentiation by regulating gene cascades specifying different aspects of somatic sexual development (3, 28, 41) . The best understood cascade is the transformer (tra)-doublesex (dsx) pathway. Sxl controls this pathway by regulating the splicing of the tra pre-mRNA. In males, the utilization of the tra default 3Ј splice site ( Fig. 1 ) leads to the production of mRNAs that have open reading frames interrupted by stop codons (8, 13) . In females, the Sxl protein promotes the utilization of a tra 3Ј splice site downstream of the stop codons, resulting in the production of mRNAs which have an intact open reading frame. The Tra protein produced from the female mRNAs then function to direct the femalespecific splicing of dsx pre-mRNAs, leading to female differentiation (12) .
Studies by Sosnowski et al. (56) have shown that Sxl promotes the female-specific splicing of tra pre-mRNA splicing by blocking the utilization of the default 3Ј splice site (Fig. 1) . Consistent with the known sequence specificity of the Sxl protein (30, 46, 49, 55, 60) , Sxl regulation requires a poly(U) run located in the polypyrimidine tract of the default 3Ј splice site. The introduction of C residues into this poly(U) run can reduce or eliminate regulation in vivo and Sxl protein binding in vitro (49, 56, 57) . Polypyrimidine tracts in 3Ј splice sites are targets for such proteins as U2AF (64, 65) that are thought to facilitate interactions between the U2 small nuclear ribonucleoprotein particle (snRNP) and the branch point of pre-mRNAs. The experiments of Valcárcel et al. (60) have suggested that Sxl may block the utilization of the tra default 3Ј splice site by competing with U2AF for binding to the polypyrimidine tract. In this model, U2AF would be excluded from the default 3Ј splice site of the tra pre-mRNA when the Sxl protein is associated with the poly(U) run. In the absence of U2AF, the U2 snRNP would be unable to form a stable complex with the default tra branch point, and instead, the snRNP would be recruited to the branch point of the female-specific 3Ј splice site by U2AF associated with its polypyrimidine tract.
While competition between Sxl and U2AF for binding to the default 3Ј polypyrimidine tract would seem to provide a plausible mechanism for the splicing regulation of tra pre-mRNAs, this mechanism does not explain Sxl autoregulation. Although the polypyrimidine tract at the 3Ј splice site of the Sxl malespecific exon (L3) consists of a long poly(U) run, this particular poly(U) run appears to be dispensable for Sxl autoregulation (29, 45) . Instead, the most important poly(U) runs are located downstream of the male exon 5Ј splice site in the intron between the male exon (L3) and exon L4. Deletion of these Sxl binding sites almost completely abolishes Sxl regulation. In addition to these downstream poly(U) runs, there are several poly(U) runs upstream of the male exon 3Ј splice site; these Sxl binding sites also appear to play an important though less critical role in regulation (29) . Surprisingly, both the upstream and downstream poly(U) runs are located at a considerable distance (Ͼ200 nucleotides [nt] ) from the splice sites they regulate (the 3Ј and 5Ј splice sites of the male exon). This large distance would seem to rule out a simple competition mechanism in which Sxl directly blocks the binding of essential splicing factors to the 3Ј and 5Ј splice sites of the male exon. Rather, one must suppose a different sort of mechanism in which Sxl protein somehow interferes not with the binding of splicing factors but with their subsequent function.
A possible hint as to this mechanism comes from genetic studies on the sans fille (snf) locus. The first snf mutation identified was the antimorphic female sterile allele, 1621. snf 1621 females are sterile because their germ cells express Sxl in the male rather than the female mode (11, 39) . This germ line defect appears to be due to a failure to properly activate and/or maintain the Sxl autoregulatory feedback loop, and the sterility of snf 1621 females can be completely rescued by gainof-function Sxl mutations which constitutively splice Sxl transcripts in the female mode (6, 47, 58) . Defects in Sxl autoregulation are also evident in the soma. In contrast to the situation with the wild type, small but readily detectable amounts of male spliced Sxl mRNA are present in the soma of snf 1621 females (11) . In addition, snf 1621 shows synergistic femalelethal interactions with loss-of-function Sxl mutations (19, 47) .
As in the germ line, these lethal interactions appear to be due to a failure in the Sxl autoregulatory feedback loop in early embryos (1) .
Consistent with the hypothesis that the snf gene product plays a critical role in Sxl splicing regulation, Flickinger and Salz (19) have recently shown that snf encodes a protein that contains two RRM domains which show extensive homology to the RRM domains of two mammalian splicing factors, U1A and U2BЉ (see also reference 25). U1A is a component of the U1 snRNP, while U2BЉ is a component of the U2 snRNP. Snf appears to be the fly equivalent of these two mammalian proteins and is present on both U1 and U2 snRNPs (35, 43 ) (see below). Studies of the mammalian U1A and U2BЉ proteins indicate that their N-terminal RRM domains are required for specific binding to the cognate small nuclear RNAs (snRNAs) while the C-terminal domains of the two proteins are dispensable (31, 51, 52) . Although the RNA binding properties of the Snf RRM domains have not been examined, genetic studies indicate that the C-terminal RRM domain is not absolutely essential, and animals homozygous for the hypomorphic snf JA2 allele, which deletes this domain, are viable (and fertile). By contrast, a deletion, snf J210 , that removes both the N-and C-terminal RRM domains is lethal for both sexes. Like the antimorphic snf allele, snf 1621 , both snf JA2 and snf J210 show synergistic female-lethal interactions with Sxl mutations; however, these interactions are less severe than those observed for snf 1621 (19) . The snf JA2 -snf J210 heteroallelic combination also exhibits defects in oogenesis similar to those found in snf 1621 females.
The effects of snf mutations on Sxl autoregulation in the germ line and soma raise the possibility that Sxl may regulate the splicing of male exon L3 by affecting the functioning of the U1 and U2 snRNPs in the splicing process. One mechanism for exerting such regulatory effects would be through protein-protein interactions between Sxl and Snf. Interactions of this sort could potentially explain how Sxl protein bound to distant poly(U) tracts in the introns upstream and downstream of the Sxl male exon is able to block the utilization of the male exon 5Ј and 3Ј splice sites. In the studies reported here, we provide evidence for a physical association between Sxl and Snf both in vivo and in vitro.
MATERIALS AND METHODS
Extracts, cross-linking, and sucrose gradients. Oregon R wild-type flies were grown at 25ЊC in population cages. Typically, 0-to 15-h embryos were collected, and low-salt sonicated nuclear extracts were prepared as described previously (49) . In order to generate embryos homozygous for the 1621 allele, flies from the Snf 1621 Sxl M1 stock were maintained at 18ЊC and embryos were collected at 18 or 25ЊC. As indicated, extracts were centrifuged through 10 to 45% sucrose gradients as described previously (49) . Gradient fractions were collected and analyzed either by trichloroacetic acid precipitation or by immunoprecipitation; in either case, analysis was followed by Western blotting (immunoblotting).
For extract cross-linking, nuclei were washed and resuspended in 50 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid)-NaOH (pH 7.5)-5 mM MgCl 2 -0.1 M NaCl (HMN) rather than the standard Tris-MgCl 2 -NaCl. A 1/20 volume of 0.1 M dimethyl 3,3Ј-dithiobis propionimidate (DTBP; Pierce) in 0.1 M HEPES-NaOH, pH 7.5, was added and left for 2 h on ice. Cross-linking was terminated by the addition of Tris-HCl, pH 7.9, to 0.05 M for 15 min on ice, and immunoprecipitations were carried out immediately. In some experiments, cross-linking was carried out similarly with dithiobis(succinimidylpropionate) (DSP; Pierce) dissolved in dimethyl sulfoxide.
Monoclonal antibodies. Anti-Sxl monoclonal antibodies m114 and m5 are described by Bopp et al. (10) . Anti-Sis-b antibody 5A10 is described by Deshpande et al. (16) . Anti-Snf antibody 4G3 (23) was from the laboratory of Walther van Venrooij. Anti-hrp40 and hrp48 antibodies 8D2 and 10D5 (36, 38) were a kind gift of Michael Matunis and Gideon Dreyfuss. Anti-snRNP D protein antibody Y12 (34) was a kind gift of Joan Steitz. Anti-snRNP B/BЈ protein antibody 7.13 (7) was a kind gift of H. C. Smith and S. Hoch.
Immunoprecipitations and Western blots. In initial experiments, mouse monoclonal antibody cell supernatants were incubated overnight with protein A-agarose (Bio-Rad Labs) or protein A-Sepharose (Pharmacia) beads, then FIG. 1. Regulated splicing of Sxl and tra. The sex-specific spliced region of Sxl encompasses approximately 4.5 kb of the complete primary transcript (21,360 nt), spanning late exons 2 to 4 (see references 5, 48, and 50 for descriptions of the Sxl transcription map). Late exon 3, the male-specific exon, is excluded from female transcripts. Late exon 2 encodes the presumptive late protein start codon plus 25 amino acids of the N terminus. Male-specific exon 3 encodes an in-frame termination codon after 16 or 22 additional amino acids (depending on the 3Ј splice site used) and introduces a frameshift after being spliced to exon 4. Female-specific splicing from L2 to L4 leads to the translation of full-length Sxl proteins (344 to 374 amino acids, depending on the isoform). Intervening sequence sizes are 2,905 or 2,923 nt between late exons 2 and 3 and 920 nt between late exons 3 and 4. The sex-specific spliced region of tra encompasses approximately 300 nt of the primary transcript (ϳ1,100 nt). A common donor site is spliced to one of two acceptor sites; the proximal site is used in both males and females, while the distal site is used exclusively in females. VOL. 16, 1996 Sxl INTERACTS WITH SPLICING FACTORS 5037
washed with IP buffer (21) , and used within 1 to 2 days. Subsequently, antibodycoated beads were covalently coupled with dimethyl pimelimidate as described previously (24) and stored in HEPES-buffered saline. Covalent coupling substantially reduced the amount of immunoglobulin heavy and light chains released from the beads after the immunoprecipitated proteins were eluted from the beads by boiling. The coupled beads could be stored in HEPES-buffered saline for periods lasting from weeks to months. For standard immunoprecipitations, 100 l of nuclear extract was combined with 100 l of a 1:2 slurry of coupled protein A beads and 500 l of IP buffer plus protease inhibitors and incubated at 4ЊC overnight. The beads were washed with IP buffer and eluted by boiling them in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer.
For standard in vitro immunoprecipitations, 0.05 to 0.1 g of purified Sxl (maltose-binding protein [MBP]-Sxl) and Snf (glutathione S-transferase [GST]-Snf) proteins was preincubated for 2 h in immunoprecipitation buffer (150 mM NaCl, 20 mM HEPES [pH 7.5], 250 mM sucrose, 0.05% Nonidet P-40) in the presence of protease inhibitors. Immunoprecipitations were carried out with anti-Sxl or anti-Snf coupled to protein A-Sepharose beads for 3 h at room temperature. The beads were collected by centrifugation, washed several times with IP buffer, and eluted by boiling them in SDS-PAGE sample buffer.
The GST-Snf fusion protein used for the in vitro coimmunoprecipitation experiments was prepared as follows. A cDNA encoding full-length Snf (a kind gift of H. Salz) was subcloned in frame into pGEX-KG to generate a GST-Snf fusion gene. Bacterial cultures carrying this plasmid were induced with isopropyl-␤-D-thiogalactopyranoside (IPTG), and the fusion protein was purified from soluble extracts by batch absorption to glutathione-Sepharose 4B (Pharmacia) and elution with free glutathione (Sigma).
SDS-acrylamide protein gels were transferred as described previously (10) or by semidry electroblotting (Sarstedt), blocked, and probed as described previously (10) . Visualization was by enhanced chemiluminescence (Amersham).
snRNA and RT-PCR assays. For reverse transcription-PCR (RT-PCR) analysis, immunoprecipitated beads were extracted with phenol-chloroform-isoamyl alcohol and then with chloroform and then by ethanol precipitation with tRNA carrier. RT and PCR were performed as described previously (29) . Two different sets of Sxl primers were used for RT and amplification. In the first set, the RT primer was 3BFill 2 (GTATTCGTTTCTGGATAT), and the PCR primers were MES 21 (CCACGAGGACGACCTGTG) and MES 20 (CGTGGACTTCACA TCGGA). In the second set, the RT primer was 3BFill 1 (CCGCAGAGGTTA TTCAG), and the PCR primers were MES 11 (TTTCAGGCGTAAGAATG AG) and Int 2 (AGTGTGACCTTGCCAGCGAGT). Primers specific for edl were kindly provided by Takuma Yamada.
For analysis of snRNAs in immunoprecipitates, washed beads from scaled-up precipitations were further exchanged into HAE (50 mM HEPES-NaOH [pH 7.9], 10 mM ammonium acetate, 1 mM EDTA), extracted, and ethanol precipitated overnight at Ϫ20ЊC with a solution containing 3 M ammonium acetate, 10 mM magnesium acetate, and 10 to 15 g of glycogen being used as carrier (33) . In the case of immunoprecipitations from DTBP-cross-linked extracts, washed beads were exchanged into HAE plus 0.5% SDS and then treated with 1 mg of proteinase K per ml at 55ЊC for 30 min, and this treatment was followed by organic extraction and ethanol precipitation with glycogen carrier as before. Protease treatment was essential for the detection of snRNAs in the Sxl immunoprecipitates from cross-linked extracts, although it seemed to be unnecessary after Snf or Y12 immunoprecipitation. RNAs were 3Ј end labelled with [␣-32 P] pCp (ICN) as described previously (33) and directly analyzed on 0.75-mm-wide, 8 M urea-Tris-borate-EDTA-8% polyacrylamide gels. The gels were soaked to remove the urea, dried, and autoradiographed.
Far Western blot analysis. Unfused Sxl and MBP-Sxl fusion proteins were prepared as described previously (49) and biotinylated with sulfo-N-hydroxysuccinimide-biotin (Pierce). Bacterial cells expressing Drosophila Snf and Orb proteins were gifts of Dan Kenan (25) and Lihua Tan, respectively. For Snf, the D-25 Snf cDNA was subcloned in the correct reading frame into the pET3C vector to give the Snf fusion gene, g10.D25. This construct was transfected into Escherichia coli BL21(DE3)pLysS. Transformants carrying the g10.D25 plasmid were induced with IPTG, and bacterial extracts were prepared. For Orb, a cDNA fragment encoding the carboxy-terminal RRM orb domains was fused in frame into the GST fusion vector, pGEX-KG. DH-5 alpha cells harboring the GST-Orb fusion plasmid were induced with IPTG and lysed with SDS-PAGE sample buffer. Total cell lysates were resolved by SDS-polyacrylamide electrophoresis; protein gels were electroblotted, probed with biotinylated Sxl proteins and then with streptavidin-horseradish peroxidase, and visualized by enhanced chemiluminescence (Amersham).
RESULTS
Heteromeric complexes between Sxl and Snf are found in vivo. The disruptions in Sxl autoregulation induced by snf mutations suggest that the Snf protein, in addition to carrying out its functions as a component of snRNPs, may be a key participant in Sxl splicing regulation. Though several different mechanisms can be envisioned, one obvious possibility is that the Sxl protein interacts directly with Snf or is associated with Snf in a multiprotein complex. Consistent with this possibility, we have previously found (49) that much of the Sxl protein present in nuclear extracts is associated with a large, RNA-containing complex that sediments near the bottom of a sucrose gradient. It would be reasonable to expect that this large Sxl complex contains additional proteins, such as Snf. To test whether Snf associates with Sxl, we first asked whether heteromeric complexes between Sxl and Snf could be detected in embryonic extracts.
For this purpose, extracts from 0-to 12-h-old embryos were immunoprecipitated with antibodies directed against Sxl. The resulting immunoprecipitates were then displayed by Western blotting and probed with antibody 4G3. This monoclonal antibody was generated with human U2BЉ as the antigen and was found to recognize an epitope in the second or C-terminal RRM domain of this snRNP protein. Subsequent studies have shown that the 4G3 antibody also recognizes this conserved epitope in the Drosophila Snf protein (19) . This result is confirmed in the experiment shown in Fig. 2A . In both total embryonic extracts ( Fig 19) . The entire Cterminal RRM domain is deleted in this hypomorphic but homozygous viable snf mutation, and the truncated Snf protein was not recognized by the 4G3 antibody ( Fig. 2A, lane 1) .
The protein recovered from Sxl immunoprecipitates of total embryo extracts is analyzed in lane 5 of Fig. 2A . As can be seen in this figure, the 4G3 antibody recognized a prominent 27-kDa band in the Sxl immunoprecipitates which comigrated with the Snf protein found in total embryo or nuclear extracts. Similar results were obtained after nuclear rather than embryonic extracts were used for immunoprecipitation with the Sxl antibody (see below). By contrast, the Snf protein could not be detected after the embryo extract was immunoprecipitated with a control monoclonal antibody directed against the basic helix-loop-helix protein Scute T4 ( Fig. 2A, lane 4) .
Since the anti-Sxl antibody immunoprecipitated Snf, we also asked whether the anti-Snf antibody could immunoprecipitate Sxl. We tested this by probing Western blots of Snf immunoprecipitates with the Sxl antibody. We were unable to detect the Sxl protein in these immunoprecipitates (data not shown). This difference may reflect, at least in part, the much greater abundance of the Snf protein in the embryonic nuclear extract and the fact that we may not recover all of the Snf protein in the extract by immunoprecipitation (also see below).
The hnRNP packaging proteins HRP40 and HRP48 are not part of the Sxl complex. The findings described above suggested that Sxl and Snf form a heteromeric complex in vivo. We wondered whether other proteins normally associated with nascent or unprocessed RNAs in the nucleus could also be immunoprecipitated with Sxl antibody. Two such RNA binding proteins are hrp40 and hrp48. These two proteins are components of heterogeneous nuclear ribonucleoprotein particle (hnRNP) complexes, and like Sxl (49) and Snf (2), they are associated with a large number of different nascent RNAs in vivo on polytene chromosomes (37, 38) . Moreover, many of the sites in polytene chromosomes which have hrp40 and/or hrp48 proteins associated with nascent transcripts also appear to have Sxl and Snf proteins. We tested whether Sxl immunoprecipitates contain either hrp40 (Fig. 2B ) or hrp48 (Fig. 2C ). Though both of these proteins could readily be detected in the starting extract, neither was found in the Sxl immunoprecipitates. These findings indicate that (under our conditions) Sxl does not form an immunoprecipitable complex with heterogeneous nuclear RNA packaging proteins hrp40 and hrp48.
The Sxl-Snf complex can be partially purified on sucrose gradients. We have previously shown that the sedimentation profile of the Sxl protein on sucrose gradients is quite different from that of Snf. Most of the Sxl protein appears to be assembled into large complexes that sediment rather rapidly, and it is found predominantly in fractions towards the bottom of the gradients. In contrast, only a small fraction of the Snf protein sediments is assembled into large complexes, and the bulk of Snf is found in fractions toward the top of the gradients (49) . A sedimentation profile quite similar to that of Snf is observed for another protein component of the Drosophila snRNPs, protein D (unpublished data). We presume that the slowly sedimenting Snf and D proteins are likely to represent free snRNPs, and these would constitute the bulk of the snRNPs recovered from cells under our isolation conditions. In contrast, the small fraction of more rapidly sedimenting Snf and D proteins is likely to represent snRNPs that are assembled, together with pre-mRNA, into spliceosome complexes (22) .
Given the difference in the sedimentation behaviors of bulk Sxl and Snf, we wondered how the Sxl-Snf complexes were distributed in the gradient. Is there a special Snf subfraction that is incorporated into the fast, rapidly sedimenting Sxl protein complexes, or is there a special Sxl subfraction that sediments with the bulk, slowly sedimenting Snf protein? To address this question, nuclear extracts prepared from 0-to 15-hold embryos were fractionated on sucrose gradients. After collection, each gradient fraction was split into three aliquots. One aliquot was used to immunoprecipitate the Sxl-Snf complexes with the Sxl antibody. The other aliquots were used to monitor the distribution of Sxl and Snf proteins in the gradient. As was observed previously, both bulk and Sxl-immunoprecipitated Sxl proteins were found in fractions in the bottom half of the gradient, with small amounts trailing upward ( Fig. 3C and data not shown). The opposite sedimentation profile was observed for bulk Snf protein; most Snf was in the upper half of the gradient, though smaller amounts were detected in fractions toward the bottom (Fig. 3A) . The distribution of the Snf protein which could be immunoprecipitated by the Sxl antibody did not resemble that of bulk Snf protein but instead was similar to that of bulk Sxl. As shown in Fig. 3B , most of the Snf protein that could be immu- VOL. 16, 1996 Sxl INTERACTS WITH SPLICING FACTORS 5039 noprecipitated by the Sxl antibody was present in fractions from the bottom half of the gradient. Since this Snf protein represents only a small subfraction of the total Snf protein, this outcome might help explain why the Snf antibody did not immunoprecipitate detectable amounts of the Sxl protein from total nuclear extracts. Consistent with this idea, we found that the Sxl protein could be detected in Snf immunoprecipitates of fractions from the bottom half but not the top half of the sucrose gradient (unpublished data). These results demonstrate that Snf is one of the components of the large Sxl complexes defined by sucrose gradient analysis. Bacterially expressed Sxl and Snf can bind to each other. While the results described in the previous section indicate that the Sxl and Snf proteins are part of an immunoprecipitable complex, the experimental procedure does not distinguish between direct interactions between these two proteins and interactions that are mediated by some other macromolecule in the complex. Hence, it was of interest to determine whether Sxl could interact directly with Snf under conditions in which no other Drosophila proteins were present. For this purpose, we first tested for Sxl-Snf interactions by the Far Western procedure. Proteins extracted from bacteria carrying a pET-Snf expression vector were resolved on an SDS-polyacrylamide gel and blotted to nitrocellulose. The blots were then probed with highly purified Sxl protein (either an unfused Sxl protein or an MBP-Sxl fusion protein [see reference 49] ) that had been labeled with a water-soluble biotin ester (see Materials and Methods). In the blot shown in Fig. 4 , lanes 4 to 8 contain increasing amounts of extract from bacterial cells expressing the Snf protein. The biotinylated Sxl protein bound to a 27-kDa protein species (plus several smaller breakdown products). A number of lines of evidence demonstrate that this protein is Snf. First, the 27-kDa species was present only after induction of the Snf expression construct. It was not found in extracts from uninduced bacterial cultures (Fig. 4, lane 2) or in extracts of bacteria expressing another Drosophila RRM RNAbinding protein, Orb (Fig. 4, lane 3) . Second, the molecular mass, 27 kDa, corresponds to that predicted for Snf. Third, a protein species with precisely the same mobility was detected with Snf antibody 4G3 on Western blots of extracts from induced but not on those from uninduced bacterial cultures (data not shown).
Sxl and Snf form an immunoprecipitated complex in vitro. To provide further evidence for a direct association between the Sxl and Snf proteins, we asked whether the bacterially expressed Sxl and Snf proteins can form an immunoprecipitable complex in vitro. In the first experiment, purified Sxl (MBP-Sxl) and Snf (GST-Snf) proteins were preincubated either together or alone, and we then tested for complex formation by using Sxl antibody for immunoprecipitation (Fig. 5A) . As shown by the Snf protein band in lane 4 of Fig. 5A , Sxl and Snf form a complex in vitro which can be immunoprecipitated by the Sxl antibody. The presence of Snf protein in the immunoprecipitate is not due to a nonspecific association between the Sxl antibodies and the Snf protein; Snf is not observed when the Sxl protein is omitted from the incubation (Fig. 5A,  lane 5) . Similarly, Snf does seem to bind nonspecifically to the beads, as it cannot be detected when another antibody (antiDorsal) is loaded onto the beads (Fig. 5A, lane 6) . Of course, the Snf protein is found when the Snf, rather than the Sxl (or Dorsal), antibody is used for immunoprecipitation (Fig. 5A,  lane 3) . Other control experiments indicate that complex formation is not mediated by either the GST or MBP domains of the two fusion proteins (data not shown).
In the second experiment, we used Snf, rather than Sxl, antibodies for immunoprecipitation and then assayed for the presence of Sxl-Snf complexes with Sxl antibodies. When both the Sxl and Snf protein are included in the preincubation, we find the Sxl protein in the Snf immunoprecipitates (Fig. 5B,  lanes 4 and 5) . In the control experiments, Sxl is not observed in the immunoprecipitates when Snf or Sxl is omitted from the preincubation mixture (Fig. 5B , lane 6 and 3, respectively) or when another antibody (anti-Dorsal) is used for the immuno -FIG. 4 . Sxl and Snf proteins interact in vitro. Purified MBP-Sxl fusion protein was biotinylated as described in Materials and Methods. The biotinylated protein was used to probe Western blots of extracts made from bacteria harboring an Snf-or Orb-expressing plasmid. Bacteria were grown to mid-log phase and then induced (or not induced) for 3 h. A total of 2.0 ml of cells was harvested by centrifugation and then resuspended in 100 l of lysis buffer containing 4% SDS, 20% glycerol, 100 mM Tris (pH 6.8), and 100 mM dithiothreitol. After boiling for 10 min and centrifugation, aliquots were loaded onto SDS gels as indicated. precipitation (Fig. 5B, lane 7 ). These findings demonstrate that Sxl and Snf form a complex in vitro which can be immunoprecipitated not only with the Sxl antibody but also with the Snf antibody. Taken together with the results of the Far Western experiments, these findings indicate that Sxl and Snf are capable of direct physical interactions in vitro and would suggest that the complexes observed in vivo could also arise from direct interactions between these two proteins. Sxl proteins are bound to Sxl transcripts in vivo. We anticipated that the in vivo complexes between Sxl and Snf might be associated with pre-mRNAs that are targets for Sxl regulation. One target is the Sxl pre-mRNA itself, which contains binding sites for Sxl proteins in the introns upstream and downstream of the male-specific exon L3. To test whether any of the Sxl protein complexes also contained Sxl transcripts, we immunoprecipitated nuclear extracts with either the Sxl antibody or a control antibody (directed against the Dorsal protein). We then determined whether Sxl transcripts were present in the immunoprecipitates by RT-PCR amplification. Two sets of Sxl primers were used for RT and amplification. The first set of primers was from exons 6 and 7, which are located downstream of the regulated splice. These were expected to yield amplified products with sizes of either 250 or 318 bp, depending on whether or not exons 6 and 7 had been spliced (250 bp for spliced products and 318 bp for unspliced products). The second set of primers was derived from the second and fourth introns; the 5Ј primer was upstream of the male exon (L3), and the 3Ј primer was downstream of exon 4 (Fig. 1) . These primers span the key Sxl binding sites in Sxl pre-mRNAs and were expected to give an RT-PCR product with a size of approximately 1.4 kb from unspliced transcripts. No product was expected from spliced transcripts. For both sets of amplification primers, appropriate downstream primers were used for RT.
The results of this analysis are presented in Fig. 6 . After immunoprecipitates with the Sxl antibody were subjected to RT-PCR amplification with the first set of primers, products with the expected sizes for both spliced and unspliced Sxl RNA were observed (Fig. 6A, lane 4) . For the second set of primers, a single band with the appropriate size for unspliced RNA was observed (Fig. 6B, lane 6) . Several experiments indicate that these RT-PCR products were derived from Sxl transcripts that were bound in an immunoprecipitable form to the Sxl protein. First, the amplification products for both sets of primers hybridized to the appropriate probes from the Sxl gene (Fig. 6) . Second, no RT-PCR-amplified products were observed when antibody directed against the Dorsal or Sis-b protein rather than Sxl was used for immunoprecipitation (Fig. 6A, lanes 3  and 5, and Fig. 6B, lanes 1 and 2) . Third, the RT-PCR products were not observed when the reverse transcriptase step was omitted (Fig. 6A, lane 2, and Fig. 6B, lane 4) . Fourth, the RT-PCR products were eliminated when the immunoprecipitates or starting nuclear extracts were treated with RNase (Fig.  6A, lanes 1 and 6, and Fig. 6B, lane 3) , whereas DNase treatment had no effect (Fig. 6A, lane 7) . Finally, no amplification products were observed when primers for another gene expressed in embryos, edl, were used (Fig. 6A, lane 8, and Fig.  6B, lane 5) .
The complex between Sxl and Snf is RNase sensitive. The immunoprecipitation of Snf protein and Sxl RNA with Sxl antibodies suggests that the Sxl protein forms multimeric complexes which contain not only Snf (and perhaps other general splicing factors) but also Sxl target RNAs. Consistent with this suggestion, we have found that the very large Sxl complexes detected on sucrose gradients can be disrupted by pretreatment of the nuclear extract with RNase, shifting bulk Sxl protein from fractions near the bottom of the gradient to slowly sedimenting fractions at the top of the gradient (49). We wondered whether RNase digestion disrupts not only the large Sxl complexes but also the association between Sxl and Snf. To determine if the in vivo interaction between the Sxl and Snf proteins is RNA dependent, we treated the nuclear extract with RNase prior to immunoprecipitation with the Sxl antibody. As can be seen from Fig. 7A , lanes 1 and 2, Snf could not be detected in the Sxl immunoprecipitates after the extract was pretreated with RNase (lane 3). RNase digestion did not affect the intrinsic immunoprecipitability of the Snf protein; Snf was detected in Snf immunoprecipitates with or without RNase treatment (Fig. 7A, lanes 4 and 5) . We also found that RNase treatment did not affect the immunoprecipitation of the Sxl protein with Sxl antibodies (data not shown). Taken together, these results suggest that RNA molecules, presumably either Sxl target RNAs or snRNP RNAs (or both), are required to stabilize the Sxl-Snf protein complexes present in nuclear extracts. VOL. 16, 1996 Sxl INTERACTS WITH SPLICING FACTORS 5041
It should be noted that these findings are different from the results obtained for the bacterially expressed proteins in Far Western blot or coimmunoprecipitation assays. In the in vitro experiments, Sxl-Snf interactions did not appear to require the addition of exogenous RNA, and the interactions were not noticeably affected by the addition of RNase (data not shown).
Snf can be released from Sxl immunoprecipitates by RNase digestion. To provide further evidence that RNA molecules are required to stabilize the Sxl-Snf complex found in nuclear extracts, we asked whether the Snf protein could be released from the Sxl immunoprecipitates by RNase digestion. For this purpose, nuclear extracts were first immunoprecipitated with the Sxl antibody. The immunoprecipitate was then split into two aliquots, and one of these was treated with RNase. After extensive washing, the proteins remaining bound to the Sxl antibody beads were analyzed by Western blotting. The results of such an experiment are presented in Fig. 7B . As before, the Snf protein was found in the untreated Sxl immunoprecipitates (Fig. 7B, lane 5) . In contrast, little or no Snf protein was present when the Sxl immunoprecipitates were treated with RNase (Fig. 7B, lanes 3 and 4) . The release of Snf from the immunoprecipitates was not due to the loss of Sxl from the beads, as the anti-Sxl beads still retained Sxl after RNase digestion (data not shown). Thus, RNase treatment could disrupt the Sxl-Snf interaction either before or after immunoprecipitation.
Snf-Sxl complexes are resistant to RNase after cross-linking. If the Sxl and Snf proteins are in close proximity in the immunoprecipitable complex, it should be possible to make the Sxl-Snf interaction RNase resistant by pretreatment with a cross-linking agent. For this purpose, we used the reversible cross-linker DTBP. This cross-linker is specific for short-distance interactions and has been used to examine the spatial relationships among components of multimeric assemblies, including snRNPs (9, 26, 27) . In our experiment, immunoprecipitates of nuclear extracts treated or not with DTBP were digested with RNase, and after extensive washing, the crosslinking was reversed and the remaining proteins were analyzed by Western blotting. As can be seen by comparing lanes 4 and 5 of Fig. 8 , cross-linking of the nuclear extract with DTBP rendered the Sxl-Snf complex resistant to RNase digestion. Negative control anti-Sis-b beads still failed to precipitate Snf from cross-linked extracts (Fig. 8, lanes 6 to 9) , indicating that the extent of cross-linking was not sufficient to generate nonspecific protein-protein interactions. Sxl immunoprecipitation was uniform under all these conditions (data not shown). Similar results were obtained with a different cross-linking reagent, dithiobis(succinimidyl propionate) (DSP) (data not shown).
Other snRNP proteins are in the cross-linked Sxl complex. Since Snf is a component of snRNPs in D. melanogaster, we wondered whether some of the other proteins associated with snRNPs are also present in the Sxl immunoprecipitates. In flies, as in mammals, the U1 and U2 snRNPs have several additional polypeptides (42, 62, 63) . Among the proteins which appear to be common constituents of the Drosophila snRNPs are B/BЈ, proteins with a size of 27 kDa, and D, a protein with a size of 16 kDa. The Drosophila B/BЈ protein is recognized by cross-reacting monoclonal antibody Y12, while cross-reacting monoclonal antibody 7.13 recognizes the Drosophila D protein (37, 42) (also see below).
We used these two monoclonal antibodies to probe blots of proteins immunoprecipitated from nuclear extracts by the Sxl antibody. As can be seen in Fig. 9B , the Y12 antibody recognized a protein species with a size of 27 kDa (B/BЈ) in total nuclear extracts (lane 3). However, this snRNP protein species was not detected in the Sxl immunoprecipitates (Fig. 9B, lane  2) . Likewise, the 16-kDa protein was readily detected in total nuclear extracts (Fig. 9A, lane 3) but was not found in the Sxl immunoprecipitates (lane 2).
It was surprising that the Sxl antibody immunoprecipitated Snf but not the B/BЈ and D proteins. A possible explanation was that the Drosophila snRNPs were unstable under our experimental conditions. To test this possibility, we used Snf antibodies for immunoprecipitation. Both the B/BЈ (data not shown) and D (Fig. 9C ) snRNP proteins were observed in the Snf immunoprecipitates of nuclear extracts. We also immuno- precipitated nuclear extracts fractionated on sucrose gradients (see above) to determine whether there were any differences between bulk Snf in the slowly sedimenting fractions and Snf associated with the large, rapidly sedimenting complexes. We found that the snRNP proteins could be coimmunoprecipitated by the Snf antibody in all gradient fractions (data not shown). Thus, the association of Snf with snRNPs does not seem to be intrinsically unstable. Two alternative hypotheses can be advanced to explain these findings. First, Sxl may only interact with free Snf, i.e., Snf that is not associated with either U1 or U2 snRNPs. Second, Sxl may interact with Snf that is associated with snRNPs; however, this interaction may destabilize the binding of Snf to the snRNP. Since it has previously been shown that snRNP proteins can be cross-linked to one another, we reasoned that it might be possible to distinguish between these alternatives by treating the Sxl complexes with DTBP prior to immunoprecipitation. According to the first hypothesis, we should be unable to immunoprecipitate other snRNP components with the Sxl antibody even after cross-linking. According to the second, both the B/BЈ and D proteins should be immunoprecipitated with the Sxl antibody after cross-linking.
In the experiment presented in Fig. 9A and B, DTBP-crosslinked nuclear extracts were immunoprecipitated with the Sxl antibody, and after extensive washing, the cross-linking was reversed and the proteins present in the immunoprecipitate were analyzed by Western blotting. As can be seen in Fig. 9A,  lane 1, and Fig. 9B , lane 1, cross-linking rendered both the D and B/BЈ snRNP proteins immunoprecipitable by the Sxl antibody. These findings argue that these snRNP proteins are also part of a Sxl complex; however, unlike Snf, they dissociate from the Sxl complex during the immunoprecipitation unless they are prestabilized by cross-linking.
An obvious question raised by these finding was whether hnRNP packaging proteins hrp40 and hrp48, which were not immunoprecipitated from untreated extracts by the Sxl antibody, would become immunoprecipitable after cross-linking. To test this, Sxl immunoprecipitates from DTBP-cross-linked nuclear extracts were probed with antibody directed against hnRNP protein hrp40. In contrast to the situation with the B/BЈ and D proteins, hrp40 was not present in Sxl immunoprecipitates of cross-linked nuclear extracts (Fig. 9D, lanes 2  and 3) . Likewise, hrp48 was not detected after cross-linking (data not shown). Thus, even though these hnRNP packing proteins probably interact with many of the same pre-mRNAs as Sxl, they are apparently not in sufficiently close proximity to be cross-linked to the Sxl complex.
Both U1 and U2 snRNAs are present in the Sxl complex. Although our cross-linking experiments indicated that the Sxl complex in nuclear extracts contains snRNPs, it was not clear which snRNPs were present, since B/BЈ and D proteins may be associated with all of the major U snRNPs. To address this problem, we analyzed the snRNAs that were immunoprecipitated from either non-cross-linked or cross-linked nuclear extracts by antibodies directed against Sxl, Snf (4G3), and B/BЈ (Y12). For these experiments, RNA isolated from the immunoprecipitates was 3Ј end labelled with [␣-32 P]pCp and RNA ligase and then resolved on 8% polyacrylamide-urea denaturing gels.
The Y12 antibody was expected to immunoprecipitate all five major U snRNAs (37) . Of these, U1, U2, and U4 snRNAs were clearly present in the Y12 immunoprecipitates with or without cross-linking (Fig. 10A, lanes 1 and 2) . U5 could not be unambiguously identified, as it should comigrate with the 5S precursor RNA (slightly above the 5S band), while U6 RNA has been reported to 3Ј end label very inefficiently.
When the Snf antibody was used, we found U1 and U2 snRNAs in the immunoprecipitates (Fig. 10B, lane 1) . The presence of both of these snRNAs is consistent with recent results obtained by more direct techniques (35, 43) , which demonstrate that Snf is associated with both U1 and U2 snRNPs. As was found when the Snf antibody was used to immunoprecipitate snRNP proteins B/BЈ and D, both the U1 and the U2 RNAs could be detected in either cross-linked or non-cross-linked extracts (data not shown).
In the Sxl immunoprecipitates, both U1 and U2 snRNAs could be detected (Fig. 10C, lanes 2 and 3) , but only after the nuclear extracts had first been cross-linked with DTBP. This result is consistent with Sxl immunoprecipitation results obtained for the B/BЈ and D proteins. Additionally, the yield of these snRNAs in the Sxl immunoprecipitates was much lower than that obtained with either the Snf or B/BЈ antibodies. The relative amounts of U1 and U2 RNAs that were recovered in the Sxl immunoprecipitates were also variable among experiments, possibly because U2 is somewhat less stable than U1 in the extracts (data not shown).
Sxl forms complexes with the Snf 1621 mutant protein. Flickinger and Salz (19) have shown that the antimorphic snf 1621 mutation substitutes a histidine for an arginine residue at position 49 in the N-terminal Snf RRM domain. This arginine residue is conserved in the mammalian U1A and U2BЉ pro- VOL. 16, 1996 Sxl INTERACTS WITH SPLICING FACTORS 5043
teins, and substitutions of other amino acids for this residue in U1A are found to lower or abolish binding of the protein to snRNA (31) . Additionally, crystallographic studies indicate that the arginine residue makes key hydrogen bonds with an adenine in the loop and a guanine in the stem of the U1 snRNA (40) . Hence, one would expect the arginine-to-histidine substitution in the 1621 allele to reduce the affinity of the Snf protein for snRNAs. Consistent with this expectation, Salz and Flickinger (47a) have obtained evidence indicating that snf 1621 mutant protein binds less tightly to snRNAs in vivo. They have proposed that the antimorphic behavior of the 1621 allele is due to the ability of the free mutant protein to compete with the snRNP-associated protein for binding to Sxl. In this case, we should find that the snf 1621 mutant protein is capable of forming a complex with the Sxl protein in vivo. To test this possibility, extracts from snf 1621 Sxl M1 embryos collected at 18ЊC (a temperature at which the 1621 mutation shows the strongest synergistic interactions with Sxl) or at 25ЊC were prepared and immunoprecipitated with the anti-Sxl anti- females are fully viable unless there is a reduction in the wild-type dose of Sxl. Second, it is also possible that it is Sxl rather than Snf which requires RNA binding to stabilize the in vivo complex (see below).
DISCUSSION
The snf gene encodes the Drosophila homolog of the mammalian snRNP proteins U1A and U2BЉ, and the Snf protein is a component of both the U1 and U2 snRNPs. Null mutations in the snf gene are late embryonic-early larval lethal. Given the central role of the U1 and U2 snRNPs in initial steps in premRNA splicing, these lethal effects are most likely due to a general disruption in RNA processing. In addition to this general function, genetic studies have shown that there is a special requirement for the snf gene in Drosophila sex determination. In the work reported here, we have attempted to understand why this generic snRNP protein is critical for promoting the female-specific splicing of Sxl pre-mRNAs. As was suggested by the genetic interactions between snf and Sxl mutations, our studies indicate that a specific subfraction of Snf associates with Sxl in a large multimeric complex. Several lines of evidence support this conclusion. First, antibodies directed against Sxl coimmunoprecipitate the Snf protein from both total embryonic extracts and nuclear extracts. Second, after nuclear extracts are fractionated on sucrose gradients, the immunoprecipitable Snf protein cosediments with large Sxl complexes and not with bulk Snf protein (or snRNPs). Third, Sxl and Snf can interact directly in the absence of other Drosophila components, as was demonstrated by Far Western blot and coimmunoprecipitation assays.
While our results indicate that Snf associates with Sxl in vivo, these Sxl-Snf complexes have some unexpected properties. The first is the apparent dissociation of Sxl-Snf complexes from the U1 and U2 snRNPs, and the second is the RNase sensitivity of the Sxl-Snf complexes. These properties are discussed further below.
Does the association of Sxl with Snf destabilize the U1 and U2 snRNPs? Although Sxl antibodies coimmunoprecipitate the Snf protein from untreated nuclear extracts, other components of the U1 and U2 snRNPs, including the two snRNAs and the B/BЈ and D snRNP proteins, are not found in the immunoprecipitates. There are two possible explanations for this finding. Either Sxl interacts with free Snf rather than with the Snf protein associated with the U1 and U2 snRNPs, or else Sxl interacts with Snf in the context of the U1 and U2 snRNPs, but the Sxl-Snf complex subsequently dissociates from the snRNPs. Our cross-linking experiments argue in favor of the latter possibility. When the nuclear extracts are cross-linked prior to immunoprecipitation, both the U1 and U2 snRNAs and the B/BЈ and D snRNP proteins can be immunoprecipitated by the Sxl antibody. That the cross-linking is specific to the macromolecules present in the Sxl multimeric complexes is suggested by the observation that other proteins which also bind to pre-mRNAs, such as hnRNP proteins hrp40 and hrp48, are not found in the Sxl immunoprecipitates of cross-linked extracts. Taken together, these observations argue that intact U1 and U2 snRNPs are initially present in the Sxl-Snf multimeric complexes but dissociate at some point during the immunoprecipitation procedure. The apparent lability of the Sxl-Snf-snRNP complex does not seem to reflect an intrinsic instability of the Snf protein in the Drosophila U1 and U2 snRNPs. When the Snf rather than the Sxl antibody is used for immunoprecipitation, the B/BЈ and D proteins as well as the U1 and U2 snRNAs can be readily immunoprecipitated without prior cross-linking. Similarly, the Snf protein has been shown to copurify with non-cross-linked snRNPs when they are isolated with other antibodies or purification procedures (25, 35) . One plausible interpretation of these findings is that the binding of Sxl to Snf induces some sort of conformational change (in Snf or the snRNP) that destabilizes the association between the Snf protein and the U1 and U2 snRNPs. If this hypothesis is correct, it is possible that the conformational change induced by Sxl binding to the snRNP may be of some relevance to the mechanism underlying the regulation of pre-mRNA splicing by the Sxl protein. Alternatively, other factors in the Sxl complex may destabilize the snRNPs.
Why is the Sxl-Snf complex RNase sensitive? The other unexpected finding is that the in vivo complex between Sxl and Snf is disrupted by RNase digestion. This RNase sensitivity raises the possibility that the Snf and Sxl proteins are in an immunoprecipitable complex not because of direct proteinprotein interactions but rather because they are adventitiously bound to the same RNA species. Several lines of evidence suggest that an entirely adventitious association via an RNA bridge is unlikely to account for our immunoprecipitation results. First, other proteins, such as the hnRNP components Hrp40 and Hrp48, that appear to be bound to many of the same RNAs as Sxl in vivo cannot be immunoprecipitated by Sxl antibodies, even after cross-linking. Second, as noted above, only Snf is found in Sxl immunoprecipitates of non-crosslinked extracts, while other constituents of the U1 and U2 snRNPs are not present. If the Sxl-Snf complexes arise simply because of an adventitious RNA bridge, we would have expected to find intact snRNPs in the non-cross-linked precipitates. Finally, we have used two different assays to show that Sxl and Snf are capable of direct interactions in vitro. Surprisingly, while RNA appears to be required to stabilize the SxlSnf complexes present in embryo or nuclear extracts, the in vitro interactions between these two proteins do not appear to require RNA. The difference between the in vitro and in vivo complexes could simply reflect the fact that the concentrations of the Sxl and Snf proteins in the in vitro assays are very much higher than those in embryo or nuclear extracts. Additionally, the in vivo Sxl-Snf complexes are likely to contain many other constituents, and one or more of these other factors might affect the interactions between Sxl and Snf.
An intriguing question is the identity of the RNA species that are required to stabilize the in vivo Sxl-Snf complexes. Since neither the U1 nor the U2 snRNA is detected in noncross-linked Sxl immunoprecipitates, these snRNAs are unlikely to be responsible for stabilizing the Sxl-Snf complex. Much more likely candidates are pre-mRNAs which contain Sxl protein binding sites. In fact, Sxl target RNAs, such as the Sxl transcripts, are found in the Sxl immunoprecipitates, while pre-mRNAs which lack Sxl binding sites are not found (see above and reference 59). Moreover, unlike the snRNAs, transcripts containing Sxl binding sites can be immunoprecipitated with the Sxl antibody without prior cross-linking of the nuclear extracts. Why might these Sxl target RNAs stabilize the Sxl-Snf complex? One plausible speculation is that the Sxl protein undergoes a conformational change upon RNA binding that facilitates or stabilizes its interaction with Snf (18) . This change could provide a specificity mechanism, ensuring that only the Sxl protein bound to a target RNA, but not free Sxl protein, can interact with Snf (and snRNPs).
A model for Sxl splicing regulation. The results presented here suggest a model (Fig. 11) to explain how Sxl proteins bound to intron sequences far from the male exon are able to block the utilization of the male exon splice sites (29, 45, 61) . Sxl proteins would bind to the poly(U) tracts in the introns upstream and downstream of the Sxl male exon (exon 3), possibly utilizing cooperative interactions among adjacent Sxl molecules to stabilize the complex (49, 61) . At the same time, U1 and U2 snRNPs would be recruited to the 5Ј and 3Ј splice sites, respectively, of the male exon and surrounding exons in accordance with the exon definition scheme of Robberson et al. (44) . Sxl proteins in the intron would then make contact with the U1 and U2 snRNPs associated with the male exon splice junctions, presumably via protein-protein interactions with Snf. These contacts would prevent the snRNPs at the male exon splice junctions from participating in subsequent splicing steps. As was suggested above, the interaction of the Sxl protein with Snf might inactivate the U1 and U2 snRNPs by inducing some sort of conformational change in the snRNPs. The Sxl proteins could also have a more passive role and simply sequester the snRNPs at the male exon splice sites. In either case, productive interactions between the U1 snRNP at the 5Ј splice site of exon 2 and the U2 snRNP at the 3Ј splice site of exon 4 would then be established (Fig. 11) . In this context, it is interesting to note that the soma-germ line regulation of P element splicing is also thought to involve interactions between splicing regulators and snRNPs (53, 54) .
Although the scheme outlined in Fig. 11 explains most of the current data concerning Sxl autoregulation, some questions about the regulatory activities of the Sxl protein remain unresolved. In polytene chromosomes, the Sxl protein is found associated with nascent transcripts at 100 or more different loci on all chromosomal arms (49) . Since Drosophila introns are usually rather A-T rich and often contain several poly(U) tracts, the binding of the Sxl protein to so many different pre-mRNAs is perhaps not altogether surprising. On the other hand, the available genetic data suggest that the Sxl gene is unlikely to regulate the splicing of such a large number of different genes. If Sxl regulates splicing by interacting with snRNPs (over a range of several hundred nucleotides), why doesn't Sxl binding lead to the aberrant processing of these other pre-mRNAs? Possibly, the kinetics of splicing is critical in determining whether the Sxl protein can alter the splicing pattern. The accumulation of incompletely processed RNAs spanning Sxl exons 2 to 4 suggests that the processing of this region of the Sxl transcripts may proceed more slowly than processing across constitutive splice sites (49) . The inefficient processing of Sxl exons 2 to 4 could potentially allow time for the postulated Sxl-snRNP interactions, while in a typical constitutive splice, the kinetics of joining would simply be too rapid for the Sxl protein to alter the splicing pattern effectively. Another factor may be the number of Sxl binding sites, their distance from splice junctions, and whether they flank the exon. Finally, the folding of intron sequences may be critical for properly juxtaposing the Sxl protein bound in intron sequences close to the appropriate splice junctions. Consistent with this possibility, Horabin and Schedl (29) found that replacing the intron between the male exon and exon 4 with a foreign sequence containing strong Sxl binding sites nonetheless only weakly restored splicing regulation.
The interaction of Sxl with the U1 and U2 snRNPs (via the Snf protein) also raises some questions about the regulation of tra splicing. In vitro studies have suggested a model in which Sxl regulates tra by competing with generic splicing factor VOL. 16, 1996 Sxl INTERACTS WITH SPLICING FACTORS 5045 U2AF for binding to the poly(U) tract just upstream of the default (nonspecific) 3Ј splice site. As a consequence, U2 snRNP is not recruited to the default branch point but instead interacts with the downstream branch point of the femalespecific splice site. This model was based on the assumption that U2AF is capable of interacting with the U2 snRNP while Sxl is not. However, the results presented here argue strongly that the Sxl protein can interact with U2 snRNPs in vivo. An additional problem with the simple U2AF competition model arises from the fact that Sxl appears to interact not only with U2 but also U1 snRNPs. Since the regulated tra intron is only 73 nt long, the Sxl protein bound to the poly(U) tracts at the default 3Ј splice site might also be able to interact with the U1 snRNP at the 5Ј splice site and interfere with its functioning. Further studies on tra splicing will clearly be required to reconcile our findings with the U2AF competition model. Finally, our model does not account for other factors known to be involved in some aspect of autoregulation. Genetic studies have shown that there are at least two other loci besides snf that are required for the female-specific splicing of Sxl transcripts. These are fl(2)d and virilizer (vir). Like snf, both fl(2)d and vir are cell vital genes which can be mutated to show preferential female effects on Sxl autoregulation. While neither of these genes has been cloned, it would not be unreasonable to suppose that these two genes encode ubiquitious splicing factors much like snf. What role the products of these genes might have in Sxl splicing regulation, and how such activities would relate to the functioning of snf proposed in our model, remains to be seen.
